Glial-Derived Neurotrophic Factor Modulates Enteric Neuronal Survival and Proliferation Through Neuropeptide Y

Gastroenterology

Volumn 131, Issue 4, 2006, Pages 1164-1178

  Anitha, Mallappa ^a   Chandrasekharan, Bindu ^a   Salgado, Joana R ^b   Grouzmann, Eric ^b   Mwangi, Simon ^a   Sitaraman, Shanthi V ^a   Srinivasan, Shanthi ^a  

^a EMORY UNIVERSITY   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE Y; NEUROTROPHIC FACTOR; PROTEIN KINASE B; RECEPTOR BLOCKING AGENT; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIUM; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL MOTILITY; IMMUNOCYTOCHEMISTRY; INTESTINE TRANSIT TIME; KNOCKOUT MOUSE; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH EMPTYING; WILD TYPE;

EID: 33749359621     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.07.019     Document Type: Article

References (57)

1. Heuckeroth R.O., Lampe P.A., Johnson E.M., and Milbrandt J. Neurturin and GDNF promote proliferation and survival of enteric neuron and glial progenitors in vitro. Dev Biol 200 (1998) 116-129
2. Gianino S., Grider J.R., Cresswell J., Enomoto H., and Heuckeroth R.O. GDNF availability determines enteric neuron number by controlling precursor proliferation. Development 130 (2003) 2187-2198
3. Young H.M., Hearn C.J., Farlie P.G., Canty A.J., Thomas P.Q., and Newgreen D.F. GDNF is a chemoattractant for enteric neural cells. Dev Biol 229 (2001) 503-516
4. Natarajan D., Marcos-Gutierrez C., Pachnis V., and de Graaff E. Requirement of signalling by receptor tyrosine kinase RET for the directed migration of enteric nervous system progenitor cells during mammalian embryogenesis. Development 129 (2002) 5151-5160
5. Barlow A., de Graaff E., and Pachnis V. Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET. Neuron 40 (2003) 905-916
6. Baloh R.H., Enomoto H., Johnson Jr. E.M., and Milbrandt J. The GDNF family ligands and receptors-implications for neural development. Curr Opin Neurobiol 10 (2000) 103-110
7. Airaksinen M.S., and Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3 (2002) 383-394
8. Taraviras S., Marcos-Gutierrez C.V., Durbec P., Jani H., Grigoriou M., Sukumaran M., Wang L.C., Hynes M., Raisman G., and Pachnis V. Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development 126 (1999) 2785-2797
9. Schuchardt A., D'Agati V., Larsson-Blomberg L., Costantini F., and Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367 (1994) 380-383
10. Moore M.W., Klein R.D., Farinas I., Sauer H., Armanini M., Phillips H., Reichardt L.F., Ryan A.M., Carver-Moore K., and Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382 (1996) 76-79
11. Pichel J.G., Shen L., Sheng H.Z., Granholm A.C., Drago J., Grinberg A., Lee E.J., Huang S.P., Saarma M., Hoffer B.J., Sariola H., and Westphal H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382 (1996) 73-76
12. Sanchez M.P., Silos-Santiago I., Frisen J., He B., Lira S.A., and Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382 (1996) 70-73
13. Cacalano G., Farinas I., Wang L.C., Hagler K., Forgie A., Moore M., Armanini M., Phillips H., Ryan A.M., Reichardt L.F., Hynes M., Davies A., and Rosenthal A. GFRα1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21 (1998) 53-62
14. Enomoto H., Araki T., Jackman A., Heuckeroth R.O., Snider W.D., Johnson Jr. E.M., and Milbrandt J. GFRα1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 21 (1998) 317-324
15. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., and Polak J.M. Neuropeptide Y distribution in the rat brain. Science 221 (1983) 877-879
16. Danger J.M., Tonon M.C., Jenks B.G., Saint-Pierre S., Martel J.C., Fasolo A., Breton B., Quirion R., Pelletier G., and Vaudry H. Neuropeptide Y: localization in the central nervous system and neuroendocrine functions. Fundam Clin Pharmacol 4 (1990) 307-340
17. Wai S.M., Kindler P.M., Lam E.T., Zhang A., and Yew D.T. Distribution of neuropeptide Y-immunoreactive neurons in the human brainstem, cerebellum, and cortex during development. Cell Mol Neurobiol 24 (2004) 667-684
18. Wang Y.N., McDonald J.K., and Wyatt R.J. Immunocytochemical localization of neuropeptide Y-like immunoreactivity in adrenergic and non-adrenergic neurons of the rat gastrointestinal tract. Peptides 8 (1987) 145-151
19. Branchek T.A., and Gershon M.D. Time course of expression of neuropeptide Y, calcitonin gene-related peptide, and NADPH diaphorase activity in neurons of the developing murine bowel and the appearance of 5-hydroxytryptamine in mucosal enterochromaffin cells. J Comp Neurol 285 (1989) 262-273
20. Fujimiya M., Itoh E., Kihara N., Yamamoto I., Fujimura M., and Inui A. Neuropeptide Y induces fasted pattern of duodenal motility via Y(2) receptors in conscious fed rats. Am J Physiol Gastrointest Liver Physiol 278 (2000) G32-G38
21. Chen C.H., Stephens Jr. R.L., and Rogers R.C. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC. Neurogastroenterol Motil 9 (1997) 109-116
22. Hellstrom P.M. Mechanisms involved in colonic vasoconstriction and inhibition of motility induced by neuropeptide Y. Acta Physiol Scand 129 (1987) 549-556
23. Wager-Page S.A., Ghazali B., Anderson W., Veale W.L., and Davison J.S. The peripheral modulation of duodenal and colonic motility in rats by the pancreatic polypeptide-fold family: neuropeptide Y, peptide YY, and pancreatic polypeptide. Peptides 14 (1993) 153-160
24. Sokolowski M.B. NPY and the regulation of behavioral development. Neuron 39 (2003) 6-8
25. Goldberg Y., Taimor G., Piper H.M., and Schluter K.D. Intracellular signaling leads to the hypertrophic effect of neuropeptide Y. Am J Physiol 275 (1998) C1207-C1215
26. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Fisher T.A., and Ji H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Pept 75-76 (1998) 231-238
27. Hansel D.E., Eipper B.A., and Ronnett G.V. Neuropeptide Y functions as a neuroproliferative factor. Nature 410 (2001) 940-944
28. Howell O.W., Doyle K., Goodman J.H., Scharfman H.E., Herzog H., Pringle A., Beck-Sickinger A.G., and Gray W.P. Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus. J Neurochem 93 (2005) 560-570
29. Thiriet N., Deng X., Solinas M., Ladenheim B., Curtis W., Goldberg S.R., Palmiter R.D., and Cadet J.L. Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J Neurosci 25 (2005) 5273-5279
30. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., and Westfall T. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50 (1998) 143-150
31. Peaire A.E., Krantis A., and Staines W.A. Distribution of the NPY receptor subtype Y1 within human colon: evidence for NPY targeting a subpopulation of nitrergic neurons. J Auton Nerv Syst 67 (1997) 168-175
32. Takei N., Sasaoka K., Higuchi H., Endo Y., and Hatanaka H. BDNF increases the expression of neuropeptide Y mRNA and promotes differentiation/maturation of neuropeptide Y-positive cultured cortical neurons from embryonic and postnatal rats. Brain Res Mol Brain Res 37 (1996) 283-289
33. Barnea A., Cho G., Lu G., and Mathis M. Brain-derived neurotrophic factor induces functional expression and phenotypic differentiation of cultured fetal neuropeptide Y-producing neurons. J Neurosci Res 42 (1995) 638-647
34. Barnea A., and Roberts J. Induction of functional and morphological expression of neuropeptide Y (NPY) in cortical cultures by brain-derived neurotrophic factor (BDNF): evidence for a requirement for extracellular-regulated kinase (ERK)-dependent and ERK-independent mechanisms. Brain Res 919 (2001) 57-69
35. Barreto-Estrada J.L., Medina-Ortiz W.E., and Garcia-Arraras J.E. The morphological and biochemical response of avian embryonic sympathoadrenal cells to nerve growth factor is developmentally regulated. Brain Res Dev Brain Res 144 (2003) 1-8
36. Creedon D.J., Tansey M.G., Baloh R.H., Osborne P.A., Lampe P.A., Fahrner T.J., Heuckeroth R.O., Milbrandt J., and Johnson E.M.J. Neurturin shares receptors and signal transduction pathways with glial cell line- derived neurotrophic factor in sympathetic neurons. Proc Natl Acad Sci U S A 94 (1997) 7018-7023
37. Srinivasan S., Anitha M., Mwangi S., and Heuckeroth R.O. Enteric neuroblasts require the phosphatidylinositol 3-kinase/Akt/Forkhead pathway for GDNF-stimulated survival. Mol Cell Neurosci 29 (2005) 107-119
38. Chalazonitis A., Rothman T.P., Chen J., and Gershon M.D. Age-dependent differences in the effects of GDNF and NT-3 on the development of neurons and glia from neural crest-derived precursors immunoselected from the fetal rat gut: expression of GFRα-1 in vitro and in vivo. Dev Biol 204 (1998) 385-406
39. Li Q., Goodchild A.K., and Pilowsky P.M. Effect of haemorrhage on the expression of neurotransmitter-related genes in rat ventrolateral medulla: a quantitative real-time RT-PCR study. Brain Res Mol Brain Res 114 (2003) 46-54
40. Grouzmann E., Aubert J.F., Waeber B., and Brunner H.R. A sensitive and specific two-site, sandwich-amplified enzyme immunoassay for neuropeptide Y. Peptides 13 (1992) 1049-1054
41. Srinivasan S., Bernal-Mizrachi E., Ohsugi M., and Permutt M.A. Glucose promotes pancreatic islet β-cell survival through a PI 3-kinase/Akt-signaling pathway. Am J Physiol Endocrinol Metab 283 (2002) E784-E793
42. Erickson J.C., Clegg K.E., and Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381 (1996) 415-421
43. Anitha M., Gondha C., Sutliff R., Parsadanian A., Mwangi S., Sitaraman S.V., and Srinivasan S. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest 116 (2006) 344-356
44. Heuckeroth R.O., Enomoto H., Grider J.R., Golden J.P., Hanke J.A., Jackman A., Molliver D.C., Bardgett M.E., Snider W.D., Johnson Jr. E.M., and Milbrandt J. Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons. Neuron 22 (1999) 253-263
45. Takahashi T., Nakamura K., Itoh H., Sima A.A., and Owyang C. Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats. Gastroenterology 113 (1997) 1535-1544
46. Greeley Jr. G.H., Hill F.L., Spannagel A., and Thompson J.C. Distribution of peptide YY in the gastrointestinal tract of the rat, dog, and monkey. Regul Pept 19 (1987) 365-372
47. El-Salhy M., Grimelius L., Wilander E., Ryberg B., Terenius L., Lundberg J.M., and Tatemoto K. Immunocytochemical identification of polypeptide YY (PYY) cells in the human gastrointestinal tract. Histochemistry 77 (1983) 15-23
48. Hamada Y., Bishop A.E., Federici G., Rivosecchi M., Talbot I.C., and Polak J.M. Increased neuropeptide Y-immunoreactive innervation of aganglionic bowel in Hirschsprung's disease. Virchows Arch A Pathol Anat Histopathol 411 (1987) 369-377
49. Larsson L.T., Malmfors G., and Sundler F. Neuropeptide Y, calcitonin gene-related peptide, and galanin in Hirschsprung's disease: an immunocytochemical study. J Pediatr Surg 23 (1988) 342-345
50. Larsson L.T., Malmfors G., Ekblad E., Ekman R., and Sundler F. NPY hyperinnervation in Hirschsprung's disease: both adrenergic and nonadrenergic fibers contribute. J Pediatr Surg 26 (1991) 1207-1214
51. Koch T.R., Roddy D.R., Carney J.A., Telander R.L., and Go V.L. Distribution, quantitation, and origin of immunoreactive neuropeptide Y in the human gastrointestinal tract. Regul Pept 21 (1988) 309-319
52. Grider J.R., and Langdon L.E. Physiological role of neuropeptide Y in the regulation of the ascending phase of the peristaltic reflex. Am J Physiol Gastrointest Liver Physiol 285 (2003) G1139-G1146
53. Mashimo H., Kjellin A., and Goyal R.K. Gastric stasis in neuronal nitric oxide synthase-deficient knockout mice. Gastroenterology 119 (2000) 766-773
54. Watkins C.C., Sawa A., Jaffrey S., Blackshaw S., Barrow R.K., Snyder S.H., and Ferris C.D. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 106 (2000) 373-384
55. Micci M.A., Kahrig K.M., Simmons R.S., Sarna S.K., Espejo-Navarro M.R., and Pasricha P.J. Neural stem cell transplantation in the stomach rescues gastric function in neuronal nitric oxide synthase-deficient mice. Gastroenterology 129 (2005) 1817-1824
56. Ishiguchi T., Amano T., Matsubayashi H., Tada H., Fujita M., and Takahashi T. Centrally administered neuropeptide Y delays gastric emptying via Y2 receptors in rats. Am J Physiol Regul Integr Comp Physiol 281 (2001) R1522-R1530
57. Elfvin L.G., Holmberg K., Emson P., Schemann M., and Hokfelt T. Nitric oxide synthase, choline acetyltransferase, catecholamine enzymes and neuropeptides and their colocalization in the anterior pelvic ganglion, the inferior mesenteric ganglion and the hypogastric nerve of the male guinea pig. J Chem Neuroanat 14 (1997) 33-49